|
|
|
|
|
|
| |
|
|
| |
Novotech is the largest independent CRO in Australia. With operations in the US, Novotech is ideally positioned to offer clinical research services on the ground in both the US and Australia/New Zealand. There is an increasingly greater demand for CROs to offer services across these two regions providing the benefits of Australia’s highly regarded cost-effective clinical trial capabilities, and at the same time take advantage of access to the much larger US market for rapid patient enrolment.
Our comprehensive range of services extend the full spectrum of clinical drug development services to the global pharmaceutical and biotechnology industries. Our Australian Head Office is situated in Sydney, with regional offices in Melbourne and Brisbane providing easy access to the most important population centres in Australia. Supported by regional staff in Perth and New Zealand, our coverage of the Australia/New Zealand region is second to none.
Our US headquarters are situated in Carlsbad, California, just north of San Diego. We provide national coverage in the United States supported by regional staff based on both coasts and key regional locations.
Our company philosophy is focussed on hiring experienced professionals with local environment expertise. Both in Australia and the US, the company boasts some of the most experienced Project Managers and CRAs in the industry. Our vision is to be recognised as the CRO of choice by all our clients in Australasia and the US, something that we are well on the way to achieving.
In addition, through key external partnerships and strategic alliances we offer worldwide reach to our clients, including Canada, Europe, Latin America and Asia. This combination of a small, flexible CRO, coupled with the ability to confidently manage very large projects allows us to move a project from initial planning stage to recruitment with dramatic speed.
Novotech Sydney is ISO 9001 certified and is regularly audited not only by clients, but external quality endorsement organisations as part of maintaining ISO credentials. |
|
| |
|
|
|
|
|
|
